BioCentury
ARTICLE | Company News

Vivalis, Aventis, Merck deal

January 27, 2003 8:00 AM UTC

Vivalis and the Hubbard ISA unit of Merial Ltd. (London, U.K.), an AVE and MRK joint venture, partnered to research avian embryonic stem cells. Vivalis is eligible for upfront payments, research fundi...